acut
respiratori
infect
ari
repres
lead
caus
morbid
mortal
worldwid
common
caus
outpati
care
adult
patient
respons
hospitalis
due
respiratori
diseas
child
popul
age
year
infant
year
age
ari
group
diseas
normal
less
day
evolut
caus
differ
microorgan
viral
aetiolog
agent
estim
present
case
infect
occur
upper
lower
respiratori
tract
upper
ari
may
includ
one
follow
condit
rhinopharyng
pharyngoamygd
sinus
acut
otiti
media
lower
ari
includ
epiglott
laryng
laryngotracheobronch
croup
bronchiti
bronchiol
pneumonia
infect
easili
transmit
via
cough
sneez
contagion
occur
inhal
aerosol
microdroplet
contain
caus
agent
anoth
import
form
contagion
direct
contact
hand
object
contamin
respiratori
secret
infect
individu
selfinocul
nasal
buccal
mucosa
andor
ocular
caviti
larg
amount
inform
avail
concern
time
distribut
influenza
virus
popul
follow
reappear
avian
influenza
subtyp
influenza
subtyp
pandem
influenza
virus
one
main
caus
agent
ari
worldwid
howev
mani
respiratori
virus
insuffici
epidemiolog
inform
avail
also
caus
ari
studi
perform
intern
level
frequent
identifi
human
respiratori
syncyti
viru
hrsv
human
parainfluenza
viru
hpiv
influenza
viru
flu
human
mastadenoviru
hmdv
rhinoviru
rv
enteroviru
ev
less
frequent
identifi
human
metapneumoviru
hmpv
primat
bocaparvoviru
pbpv
human
coronaviru
hcov
virus
serv
caus
agent
ari
occur
outsid
influenza
season
rate
posit
drop
although
larg
percentag
ari
caus
viral
infect
caus
virus
specif
identifi
major
case
due
difficulti
high
number
possibl
aetiolog
agent
similar
symptom
among
ari
caus
differ
aetiolog
agent
emerg
new
virus
new
variant
previous
describ
virus
high
cost
detect
test
thu
littl
inform
avail
concern
preval
season
virus
mainli
undevelop
countri
possibl
carri
type
studi
regular
basi
unusu
investig
caus
agent
acut
respiratori
infect
import
order
lead
develop
vaccin
target
preval
virus
reduc
unnecessari
prescript
antibiot
antivir
oseltamivir
phosphat
addit
analysi
like
help
identifi
age
group
suscept
infect
viru
order
take
necessari
action
prevent
treatment
therefor
aim
determin
viral
aetiolog
ari
sampl
patient
present
respiratori
symptomatolog
neg
influenza
rtqpcr
test
evalu
presenc
noninfluenza
respiratori
virus
circul
mexican
popul
differ
season
year
anal
everi
pharyng
exud
sampl
receiv
laboratorio
central
de
lce
central
epidemiolog
laboratori
epidemiolog
week
week
accord
follow
criteria
sampl
previou
neg
result
influenza
rtqpcr
met
one
follow
oper
case
definit
influenzalik
ill
ili
person
age
present
fever
greater
equal
cough
cephalalgia
accompani
one
follow
symptom
rhinorrhoea
coryza
arthralgia
myalgia
prostrat
odynophagia
thorac
pain
abdomin
pain
nasal
congest
patient
five
year
age
irrit
consid
cardin
sign
place
cephalalgia
patient
older
year
fever
requir
cardin
symptom
sever
acut
respiratori
infect
sari
person
age
present
difficulti
breath
accompani
fever
greater
equal
cough
one
follow
symptom
poor
gener
condit
thorac
pain
polypnoea
acut
respiratori
distress
syndrom
ard
death
associ
ili
sari
total
sampl
select
tabl
total
nucleic
acid
obtain
pharyng
exud
sampl
taken
dacron
swab
copan
diagnost
corona
calif
catalog
store
viral
transport
medium
univers
viral
transport
system
east
rutherford
new
jersey
eua
catalog
prior
use
magna
pure
lc
instrument
roch
diagnost
mannheim
germani
autom
technolog
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
mannheim
germani
catalog
use
accord
manufactur
instruct
iii
onestep
rtqpcr
system
kit
invitrogen
carlsbad
eua
catalog
use
fast
realtim
pcr
system
appli
foster
citi
eua
amplifi
viral
genet
materi
primer
probe
use
follow
virus
hmpv
hrsv
hpiv
betacoronaviru
human
coronaviru
hcov
hmdv
rv
ev
pbpv
human
rnase
p
rp
gene
use
intern
control
tabl
virus
evalu
uniplex
reaction
follow
reaction
mixtur
reaction
mix
primer
probe
enzym
rnasefre
water
total
nucleic
acid
follow
thermocycl
condit
use
one
cycl
min
min
cycl
sec
min
dna
rna
lyophiliz
vircel
use
posit
control
evalu
virus
sampl
present
amplif
viral
marker
plu
intern
control
consid
posit
result
sampl
without
amplif
viral
marker
amplif
intern
control
consid
neg
result
sampl
present
amplif
intern
control
consid
inadequ
descript
statist
use
analys
preval
virus
includ
studi
percentag
given
confid
interv
chisquar
test
homogen
independ
fisher
exact
test
use
compar
categor
variabl
pvalu
consid
signific
anova
student
ttest
use
hypothesi
test
quantit
variabl
analys
perform
spss
statist
version
softwar
graphic
gener
centurion
xviii
softwar
inform
biolog
specimen
use
present
studi
traceabl
patient
data
ident
sampl
use
anonym
way
studi
approv
ethic
committe
research
committe
nation
committe
scientif
research
instituto
mexicano
del
seguro
social
registr
number
sampl
analys
male
femal
averag
age
year
minimum
maximum
extrem
year
respect
popul
divid
age
group
base
age
rang
includ
instituto
mexicano
del
seguro
social
imss
mexican
social
secur
institut
health
card
accord
stratif
sampl
distribut
follow
sampl
correspond
children
year
age
young
peopl
year
age
adult
year
age
adult
year
older
tabl
unintentionallya
analys
sampl
collect
patient
three
geograph
area
countri
follow
north
zone
baja
california
baja
california
sur
sonora
chihuahua
coahuila
nuevo
durango
sinaloa
zacateca
san
lui
tamaulipa
nayarit
aguascalient
sampl
central
zone
guanajuato
hidalgo
morelo
jalisco
colima
estado
de
tlaxcala
distrito
feder
mexico
citi
sampl
south
zone
puebla
guerrero
veracruz
oaxaca
tabasco
chiapa
campech
quintana
roo
sampl
fig
addit
data
analys
base
age
group
tabl
file
total
sampl
analys
posit
least
viru
femal
patient
n
male
patient
n
signific
differ
group
p
total
posit
sampl
rv
highest
number
detect
follow
hrsv
hmpv
hmdv
ev
pbpv
virus
present
percentag
although
togeth
account
posit
case
detect
tabl
total
case
coinfect
identifi
correspond
total
analys
sampl
posit
sampl
among
observ
coinfect
caus
virus
virus
virus
fig
virus
often
identifi
case
coinfect
rv
case
follow
hrsv
hmdv
interestingli
case
pbpv
despit
causal
agent
coinfect
coinfect
repres
pbpv
case
detect
behaviour
hmdv
similar
case
viru
present
involv
combin
virus
case
repres
signific
associ
p
coinfect
tabl
commonli
observ
viral
combin
hmdv
rv
follow
rv
hrsv
although
occur
time
coinfect
virus
involv
agent
case
hrsv
hmdv
pbpv
comparison
perform
day
hospit
requir
patient
neg
sampl
sampl
posit
singl
viru
virus
detect
analysi
clinic
data
show
hospit
significantli
higher
neg
sampl
posit
one
viru
coinfect
day
averag
respect
p
observ
tendenc
averag
number
comorbid
symptom
neg
sampl
versu
posit
sampl
p
neg
sampl
posit
sampl
p
respect
nevertheless
number
clinic
symptom
comorbid
greater
ari
posit
singl
viru
patient
coinfect
p
tabl
highest
number
posit
case
occur
group
age
year
second
highest
group
age
year
older
follow
group
final
age
group
repres
signific
differ
p
consist
age
group
compris
coinfect
interestingli
group
contain
pbpv
infect
hmdv
infect
hrsv
case
fig
conduct
analysi
overal
behaviour
virus
period
cover
studi
observ
month
high
low
posit
differ
significantli
p
fig
show
monthli
behaviour
viru
month
novemb
present
highest
percentag
case
year
fig
analysi
perform
season
observ
differ
four
season
year
p
gener
summer
significantli
lower
proport
posit
sampl
p
wherea
fall
highest
proport
p
howev
individu
trend
virus
instanc
spring
march
june
account
greatest
proport
rv
hmdv
case
respect
contrast
hrsv
ev
case
detect
fall
septemb
decemb
winter
decemb
march
present
highest
preval
hmpv
virus
hcov
hcov
hpiv
pbpv
hcov
detect
throughout
year
season
trend
observ
p
approxim
million
ari
case
occur
annual
mexico
case
caus
larg
varieti
aetiolog
agent
howev
main
purpos
epidemiolog
surveil
countri
detect
antigen
variat
influenza
present
season
determin
chang
vaccin
composit
instituto
de
referencia
indr
institut
epidemiolog
diagnosi
refer
implement
differenti
diagnosi
influenza
includ
respiratori
virus
due
moment
mexico
enough
epidemiolog
inform
great
divers
virus
caus
acut
respiratori
infect
lack
inform
make
physician
search
influenza
therefor
request
confirmatori
test
laboratori
whole
year
even
influenza
season
season
compris
octob
may
lead
useless
neg
influenza
result
case
without
identifi
real
causal
agent
ari
mexico
problem
direct
implic
patient
clinician
know
causal
agent
patient
receiv
suitabl
treatment
also
implic
affect
whole
societi
ignor
circul
pattern
incid
respiratori
virus
limit
prevent
action
health
institut
accord
data
secretari
health
approxim
sampl
patient
ari
receiv
confirm
influenza
viru
infect
outsid
flu
season
neg
differ
strain
viru
remain
without
defin
aetiolog
therefor
object
studi
determin
viral
aetiolog
infect
analys
behaviour
noninfluenza
respiratori
virus
mexican
popul
begin
end
influenza
season
sampl
collect
one
year
evalu
determin
presenc
hmpv
hrsv
hpiv
hcov
hmdv
rv
ev
pbpv
respiratori
virus
share
symptom
influenza
rare
suspect
confus
influenza
contrast
studi
countri
investig
issu
studi
includ
sampl
correspond
age
group
region
countri
therefor
studi
popul
best
repres
demograph
distribut
ari
countri
contrast
preval
studi
ari
age
group
normal
analys
data
limit
singl
region
countri
studi
age
patient
region
countri
sampl
came
includ
inclus
exclus
criteria
therefor
popul
analys
studi
repres
better
demograph
distribut
ari
countri
type
studi
help
provid
relev
data
develop
treatment
prevent
strategi
current
avail
antivir
agent
vaccin
primarili
direct
influenza
infect
howev
proport
ari
caus
differ
influenza
viral
agent
neglig
detect
rang
noninfluenza
respiratori
virus
span
studi
conduct
worldwid
depend
factor
studi
design
studi
popul
detect
techniqu
use
period
cover
studi
case
preval
analys
virus
within
cite
rang
preval
virus
rv
hrsv
hmpv
viru
detect
result
consist
studi
type
parainfluenza
viru
lowest
detect
frequenc
howev
evid
preval
increas
reduc
consist
result
rv
identifi
common
viru
ari
case
sever
studi
presenc
influenza
respiratori
virus
throat
swab
determin
molecular
techniqu
design
use
commerci
panel
equal
data
observ
studi
mexican
children
viru
major
aetiolog
agent
common
cold
howev
may
also
involv
seriou
ari
primarili
observ
patient
underli
comorbid
asthma
chronic
pulmonari
diseas
indic
certain
degre
opportun
similar
rv
hrsv
identifi
high
proport
studi
conduct
poland
individu
analys
without
age
select
mexico
children
year
age
studi
trend
also
observ
studi
higher
preval
influenza
observ
hrsv
associ
pathogenesi
asthma
importantli
hrsv
lead
caus
child
mortal
caus
virus
third
preval
viru
hmpv
mexico
first
studi
presenc
viru
determin
publish
subsequ
mexican
studi
demonstr
import
child
popul
studi
diaz
et
al
demonstr
hmpv
mostli
associ
sever
acut
respiratori
infect
instead
mild
moder
infect
import
differenti
diagnosi
respiratori
virus
sampl
neg
influenza
result
becom
appar
observ
preval
three
main
virus
identifi
studi
well
associ
sever
case
death
especi
child
popul
coinfect
repres
posit
sampl
percentag
rang
studi
also
includ
variou
age
group
howev
much
higher
percentag
found
studi
popul
compos
children
year
age
result
confirm
viral
coinfect
common
especi
child
popul
coinfect
occur
year
age
group
result
could
attribut
slower
viral
elimin
due
stilldevelop
immun
system
viru
involv
coinfect
pbpv
case
identifi
found
togeth
anoth
viru
studi
report
identif
percentag
viru
conjunct
agent
rang
howev
preval
asymptomat
patient
also
high
call
question
whether
pbpv
capabl
gener
diseas
particip
facilit
anoth
agent
infect
host
present
cellular
anim
model
still
develop
viru
therefor
evid
need
confirm
hypothesi
yet
exist
clinic
perspect
whether
presenc
coinfect
result
seriou
case
poor
prognost
factor
matter
controversi
within
scientif
commun
although
studi
report
case
characterist
report
author
suggest
coinfect
synonym
clinic
differ
greater
sever
studi
et
al
invers
relationship
found
number
virus
detect
hospit
time
well
need
oxygen
therapi
similar
relationship
observ
studi
canducci
et
al
greater
hypoxia
lengthier
hospit
time
infect
caus
pure
hrsv
compar
coinfect
studi
ari
caus
singl
viru
also
present
lengthier
hospit
time
ari
caus
virus
although
differ
statist
signific
notabl
similar
estim
preval
differ
report
rang
discrep
sever
associ
viral
coinfect
attribut
detect
techniqu
employ
popul
time
period
studi
virus
studi
short
period
time
compris
studi
limit
number
sampl
possibl
state
suggest
certain
season
behavior
studi
virus
gener
peak
respiratori
infect
occur
period
novemb
april
countri
northern
hemispher
influenza
season
well
known
mexico
worldwid
howev
season
respiratori
virus
well
known
accord
result
highest
preval
virus
mexico
appear
occur
octob
march
autumn
winter
coincid
influenza
season
detect
significantli
higher
novemb
month
mark
decreas
nation
mean
temperatur
accord
cui
et
al
mean
temperatur
key
climat
paramet
associ
preval
mani
respiratori
virus
virus
surviv
andor
replic
better
low
temperatur
hand
viega
et
al
propos
mucu
releas
cilia
reduc
temperatur
respiratori
tract
lower
consequ
local
innat
immun
respons
neutrophil
natur
killer
nk
cell
migrat
also
reduc
therebi
promot
viral
infect
climat
factor
may
also
indirectli
favour
transmiss
effici
low
temperatur
induc
chang
social
behaviour
favour
interior
overcrowd
increas
likelihood
close
contact
transmiss
infect
reason
common
suggest
avoid
go
school
work
undergo
infecti
process
result
suggest
virus
mark
season
trend
virus
winter
preval
hmpv
higher
season
year
circul
hmpv
particular
predomin
colder
season
mark
reduct
preval
observ
spring
disappear
complet
summer
furthermor
studi
conduct
mexico
citi
children
year
age
analys
studi
perform
china
hospit
patient
report
highest
preval
hmpv
occur
winter
season
overlap
virus
similar
hmpv
author
agre
hrsv
viru
circul
preferenti
colder
season
studi
demonstr
hrsv
caus
ari
season
year
consist
studi
report
preval
highest
fall
winter
convers
rv
seem
viru
best
suit
climat
condit
countri
signific
differ
preval
differ
season
accord
result
studi
conduct
china
optim
circul
temperatur
rang
viru
similar
rang
mean
mexican
temperatur
may
justifi
high
preval
month
year
howev
despit
inform
report
date
factor
affect
circul
differ
virus
remain
unclear
annual
research
need
establish
season
virus
accuraci
precis
although
influenza
one
main
caus
agent
respiratori
infect
worldwid
vital
import
determin
preval
time
causal
agent
studi
identifi
noninfluenza
respiratori
virus
occur
season
year
studi
provid
evid
preval
season
wide
rang
respiratori
virus
circul
mexico
constitut
risk
popul
addit
data
suggest
includ
test
wide
diagnost
algorithm
influenza
could
reduc
use
unnecessari
antibiot
reduc
hospitalis
time
enrich
nation
epidemiolog
data
regard
infect
caus
virus
